Literature DB >> 34326359

A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation.

Ignacio Rodriguez-Polo1,2, Sophie Mißbach1,2, Stoyan Petkov1,2, Felix Mattern3, Anna Maierhofer3, Iga Grządzielewska1,4, Yuliia Tereshchenko1,4, Daniel Urrutia-Cabrera1,5, Thomas Haaf3, Ralf Dressel2,6, Iris Bartels7, Rüdiger Behr8,9.   

Abstract

Non-human primates (NHPs) are, due to their close phylogenetic relationship to humans, excellent animal models to study clinically relevant mutations. However, the toolbox for the genetic modification of NHPs is less developed than those for other species like mice. Therefore, it is necessary to further develop and refine genome editing approaches in NHPs. NHP pluripotent stem cells (PSCs) share key molecular signatures with the early embryo, which is an important target for genomic modification. Therefore, PSCs are a valuable test system for the validation of embryonic genome editing approaches. In the present study, we made use of the versatility of the piggyBac transposon system for different purposes in the context of NHP stem cell technology and genome editing. These include (1) Robust reprogramming of rhesus macaque fibroblasts to induced pluripotent stem cells (iPSCs); (2) Culture of the iPSCs under feeder-free conditions even after removal of the transgene resulting in transgene-free iPSCs; (3) Development of a CRISPR/Cas-based work-flow to edit the genome of rhesus macaque PSCs with high efficiency; (4) Establishment of a novel protocol for the derivation of gene-edited monoclonal NHP-iPSC lines. These findings facilitate efficient testing of genome editing approaches in NHP-PSC before their in vivo application.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34326359     DOI: 10.1038/s41598-021-94419-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  24 in total

1.  Transgenic rhesus monkeys produced by gene transfer into early-cleavage-stage embryos using a simian immunodeficiency virus-based vector.

Authors:  Yuyu Niu; Yang Yu; Agnieszka Bernat; Shihua Yang; Xiechao He; Xiangyu Guo; Dongliang Chen; Yongchang Chen; Shaohui Ji; Wei Si; Yongqin Lv; Tao Tan; Qiang Wei; Hong Wang; Lei Shi; Jean Guan; Xuemei Zhu; Marielle Afanassieff; Pierre Savatier; Kang Zhang; Qi Zhou; Weizhi Ji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-24       Impact factor: 11.205

Review 2.  Genetics of human cardiovascular disease.

Authors:  Sekar Kathiresan; Deepak Srivastava
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos.

Authors:  M J Wolfgang; S G Eisele; M A Browne; M L Schotzko; M A Garthwaite; M Durning; A Ramezani; R G Hawley; J A Thomson; T G Golos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 4.  Why primate models matter.

Authors:  Kimberley A Phillips; Karen L Bales; John P Capitanio; Alan Conley; Paul W Czoty; Bert A 't Hart; William D Hopkins; Shiu-Lok Hu; Lisa A Miller; Michael A Nader; Peter W Nathanielsz; Jeffrey Rogers; Carol A Shively; Mary Lou Voytko
Journal:  Am J Primatol       Date:  2014-04-10       Impact factor: 2.371

5.  Generation of transgenic non-human primates with germline transmission.

Authors:  Erika Sasaki; Hiroshi Suemizu; Akiko Shimada; Kisaburo Hanazawa; Ryo Oiwa; Michiko Kamioka; Ikuo Tomioka; Yusuke Sotomaru; Reiko Hirakawa; Tomoo Eto; Seiji Shiozawa; Takuji Maeda; Mamoru Ito; Ryoji Ito; Chika Kito; Chie Yagihashi; Kenji Kawai; Hiroyuki Miyoshi; Yoshikuni Tanioka; Norikazu Tamaoki; Sonoko Habu; Hideyuki Okano; Tatsuji Nomura
Journal:  Nature       Date:  2009-05-28       Impact factor: 49.962

Review 6.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01

Review 7.  An overview on the correlation of neurological disorders with cardiovascular disease.

Authors:  C K Firoz; Nasimudeen R Jabir; Mohd Shahnawaz Khan; Maged Mahmoud; Shazi Shakil; Ghazi A Damanhouri; Syed Kashif Zaidi; Shams Tabrez; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-09-06       Impact factor: 4.219

Review 8.  Therapeutic Genome Editing in Cardiovascular Diseases.

Authors:  David M German; Shoukhrat Mitalipov; Anusha Mishra; Sanjiv Kaul
Journal:  JACC Basic Transl Sci       Date:  2019-02-25

9.  Gene expression across mammalian organ development.

Authors:  Margarida Cardoso-Moreira; Jean Halbert; Delphine Valloton; Britta Velten; Chunyan Chen; Yi Shao; Angélica Liechti; Kelly Ascenção; Coralie Rummel; Svetlana Ovchinnikova; Pavel V Mazin; Ioannis Xenarios; Keith Harshman; Matthew Mort; David N Cooper; Carmen Sandi; Michael J Soares; Paula G Ferreira; Sandra Afonso; Miguel Carneiro; James M A Turner; John L VandeBerg; Amir Fallahshahroudi; Per Jensen; Rüdiger Behr; Steven Lisgo; Susan Lindsay; Philipp Khaitovich; Wolfgang Huber; Julie Baker; Simon Anders; Yong E Zhang; Henrik Kaessmann
Journal:  Nature       Date:  2019-06-26       Impact factor: 49.962

Review 10.  Genetic engineering in nonhuman primates for human disease modeling.

Authors:  Kenya Sato; Erika Sasaki
Journal:  J Hum Genet       Date:  2017-12-04       Impact factor: 3.172

View more
  1 in total

Review 1.  Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies.

Authors:  Ignacio Rodriguez-Polo; Rüdiger Behr
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.